David A. Siegel Adaptive Biotechnologies Corp Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,800 shares of ADPT stock, worth $36,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,800
Previous 10,000
8.0%
Holding current value
$36,396
Previous $49,000
30.61%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ADPT
# of Institutions
201Shares Held
146MCall Options Held
2.6KPut Options Held
143K-
Viking Global Investors LP30MShares$101 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$43.4 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$39 Million0.35% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$37.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.6MShares$35.6 Million0.24% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $481M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...